Delivery Order SPE2DB20D2104-SPE2DB24FU49W
Award Date
6/3/24
Potential Completion Date
6/4/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.98 fixed-price delivery order is for the supply of LINZESS 145 MCG capsules and has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,086.08 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG capsules. The $1,415.00 firm fixed price delivery order has an ultimate completion date of October 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,773.31 firm fixed-price delivery order is for the supply of LINZESS 145 MCG capsules. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,048.22 for the supply of LINZESS 145 MCG CAPSULE UU 30S. The contract is a firm-fixed-price award with an ultimate completion date of March 14, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. This award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,945.17, is a delivery order for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.10 delivery order contract is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price type, with a completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valid...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,000.84 firm fixed-price contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a prescription medication. The contract has an ultimate completion date of February 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,573.33 Firm Fixed Price Delivery Order is for the supply of LINZESS 145 MCG CAPSULE, a pharmaceutical product, with a completion date of July 18, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,427.98 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S and has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...